The proliferation of new narcotics developed to circumvent existing drug laws poses a serious health problem, the United Nations drugs control body said on Tuesday.
(Medical Xpress)—Analysis of religiosity in childhood and adulthood suggests that individuals who change in religiosity over time are at greater risk of using psychoactive substances, including alcohol, ...
The European Commission on Tuesday urged member countries to coordinate their fight against "legal highs", the use of medical drugs and industrial chemicals for recreation which has killed many unwary thrill-seekers.
New drugs marketed as "legal highs" and "designer drugs" are emerging fast and in great numbers, and authorities are struggling to keep up, a new UN report warned Wednesday.
Australia imposed an interim ban on 19 synthetic cannabis and cocaine-like drugs on Sunday as part of a crackdown on the psychoactive substances which mimic the highs of their illegal counterparts.
The last few years have seen the emergence of a new drug problem in so-called "bath salts"—actually "designer stimulants," packaged and sold in ways that skirt drug laws. A review and update on these designer drugs is presented ...
New synthetic psychoactive substances are making their way into Europe where the Internet is becoming a big challenge in the fight against illicit drugs, the continent's drug agency warned Tuesday.
Designer drugs are multiplying at a worrying rate and increasingly sending users to hospital, a UN-affiliated report said Tuesday, calling for international efforts to stem the spread of these substances.
The use of legal substances that mimic the effects of illegal drugs appears to be on the rise in Australia, yet little is known about their long-term impact on users.
(Medical Xpress)—Millions of Americans take antidepressants such as Prozac, Effexor, and Paxil, but the explanations for how they work never satisfied René Hen, a professor of psychiatry, neuroscience ...
The rapid emergence of synthetic new drugs, often sold online as "legal highs," represents a significant challenge for policy makers in the coming decade, a European Union drugs agency said Tuesday.